Muller et al., 1994). While this is the first source of such Erasmus University Medical Center fully competent HSCs, other in vivo transplantation 3000 DR Rotterdam scenarios (injection into the placenta or YS cavity of The Netherlands embryos, injection into the liver of conditioned neonatal recipients, or intravenous injection into immunodeficient recipients) have revealed long-term repopulating Summary cells with multipotential hematopoietic properties at earlier embryonic stages (Cumano et al., 2001; Toles et In the midgestation murine embryo, several major al., 1989; Weissman et al., 1978; Yoder et al., 1997a, vascular tissues contain hematopoietic stem cell (HSC)
Cross, 2001). The chorioallantoic placenta forms at this concerning the origin of definitive hematopoiesis in the junction, and, thereafter, the allantois contributes the murine embryo. As the yolk sac (YS) is the first tissue fetal vascular and associated stromal components, induring development to produce blood cells (primitive cluding the umbilical vessels (Downs et al., 1998). Intererythroid cells), it was assumed to be the sole source estingly, the placenta was recently demonstrated to of hematopoiesis in the mammalian embryo (Moore and contain clonogenic hematopoietic progenitors, includ-Metcalf, 1970). However, accumulating evidence pointed ing CFU-GMs, CFU-GEMMs, BFU-Es, and HPP-CFCs to another anatomical site within the embryo as the (Alvarez-Silva et al., 2003) . Moreover, between E10 and source of definitive hematopoietic cells. Avian and am-E12, these progenitors were present at numbers higher phibian embryo grafting experiments demonstrated than those found in the YS and fetal liver. However, it that the adult hematopoietic system was derived priwas not investigated whether the placenta also conmarily from the embryonic part of the conceptus in a tains HSCs. mesodermal region containing the dorsal aorta and A well-recognized feature shared by embryonic pronephros (Chen and Turpen, 1995; Dieterlen-Lievre, hematopoietic sites is the associated development of 1975). More recent experiments in amphibian embryos the vascular and hematopoietic systems. A wide range have confirmed these results and further demonstrate of evidence has supported hemangioblasts and hemothat distinct blastomeres in the 32-cell stage give rise genic endothelium as the presumptive precursors to to hematopoietic cells of the YS and embryo body emerging hematopoietic cells (reviewed in Dieterlen-(Ciau -Uitz et al., 2000) . In the mouse, it was more re-Lievre, 1998; Nishikawa, 2001; Ottersbach and Dziercently shown that the first hematopoietic stem cells zak, 2005; see http://Eurekah.com for the online version (HSCs; cells fully competent to long-term reconstitute of this chapter). In Ly-6A GFP transgenic mice expressthe entire adult hematopoietic system after transplantaing the green fluorescent protein (GFP) under the regution into irradiated, adult recipients) are autonomously latory elements of the HSC marker Sca-1, we demongenerated in the intraembryonic aorta-gonad-mesostrated that all HSC activity was confined to the GFP + nephros (AGM) region, and more precisely the aortafraction in AGM, fetal liver, and adult bone marrow tissues (de Bruijn et al., 2002; Ma et al., 2002) . We further showed by immunohistologic analysis of E9-E11 em-bryos that GFP expression localized to the endothelial vancing toward the GFP + ectoplacental cone. Most strikingly, at E12, high levels of GFP expression are layer of the dorsal aorta, the vitelline artery, and the major blood vessels of the YS. The common expression found in the embryonic vessels of the placenta ( Figure  1I ). Thus, similar to the other major hematopoietic tis-of this transgene, as well as other markers, in endothelial cells and AGM HSCs highlights the close relation-sues in the embryo, the placental vasculature expresses Ly-6A GFP, suggesting a potential for hemato-ship between these two cell types and supports the notion that HSCs derive from specialized "hemogenic" poietic activity. endothelial cells that are present for a brief period of time during midgestation.
Placenta Contains Potent HSCs Beginning In extending our analysis of these HSC marker transat Midgestation genic embryos to earlier times in development, E6-Previously, Alvarez-Silva et al. (2003) have found hema-E7.5, we found high GFP expression restricted to extratopoietic progenitor activity in the placenta. However, embryonic tissues: the ectoplacental cone and the the presence of HSC activity was not tested. To examextraembryonic ectoderm. Since these sites contribute ine the placenta for potent, adult-engrafting HSCs, we to the placenta, the temporal expression was examobtained E9-E12 embryos (human b-globin transgenic), inedin the placenta, beginning from E9, just after the dissected the placenta (without the decidua or umbilifusion of the chorion and the allantois. At all stages cal vessels), made a single-cell suspension, and inexamined, we found high-level GFP expression rejected various doses of cells (placental tissue equivastricted to the embryonic/fetal vessels of the placental lents) into irradiated, adult recipients. Engraftment was labyrinth (the layer of the placenta in which the embrytested by peripheral blood DNA PCR for the presence onic circulation comes into contact with the maternal of the donor (human b-globin) marker at 1 and greater circulation). This observation prompted us to test for than 4 months posttransplantation. As shown in Table HSC activity in the placenta. We show here that adult-1, no engrafted mice were found after transplantation of type HSCs are indeed present in the placenta, starting E9 or E10 placenta cells. However, potent engraftment from E11, and that they are again exclusively found in (greater than 10% donor cell contribution) was found the Ly-6A GFP + fraction. Moreover, other HSC markers beginning at E11 and was present at high levels at E12. colocalize with GFP + cells in the labyrinth region. These
We tested these recipients for multilineage engraftresults suggest that the placenta, together with other ment. High-level engraftment was observed in all hemadistinct embryonic tissues, contribute to the adult hemtopoietic tissues and in sorted myeloid, T lymphoid, atopietic system. and B lymphoid cells in recipients of E11 (not shown) and E12 placental cells (Figure 2A) . Moreover, the transplantation of the bone marrow from these primary re-Results cipients into secondary, adult, irradiated recipients resulted in similar high-level repopulation at greater than Expression of Ly-6A GFP in the Highly 4 months posttransplantation (six positive/six injected, Vascularized Tissues of the Embryo range of repopulation: 75%-98%). Frequency analysis Previously, we have shown that all HSCs in the AGM of HSCs within the E12 placenta showed 1 HSC per region of the midgestation mouse embryo are localized 49,713 cells, with approximately 12 HSCs per placenta to the Ly-6A GFP + aortic fraction of cells (de Bruijn et (as determined by Poisson statistics). Thus, the plaal., 2002). GFP expression is found in some endothelial centa contains potent repopulating cells that fulfill all cells of the dorsal aorta, and an even stronger expresthe established functional criteria of HSCs. However, in sion is found in the endothelial cells lining the vitelline contrast to the AGM, we found that HSC numbers in artery ( Figure 1A) . Hematopoietic clusters along the luthe placenta were not expanded during an organ culmen of the aorta and vitelline arteries also contain GFP + ture step (data not shown). This is most likely due to cells ( Figure 1B) . Moreover, strong GFP expression is the large size of the placenta (compared to the AGM), found in the umbilical artery ( Figure 1E) In addition to these known hematopoietic tissues, the placenta is also highly vascularized, and, thus, we ex-All Placental HSCs Are Contained within the GFP + Fraction amined this tissue for expression of the Ly-6A GFP marker. As the placenta is formed from both maternally We next performed flow cytometric analysis to determine the number and phenotypic characteristics of and embryonic-derived cells, the Ly-6A GFP transgene was transmitted only through the male germline. Al-GFP + cells in the midgestation placenta. E12 placenta cells were stained with antibodies specific for CD31 ready in the prestreak-stage embryo, high GFP expression is also found in the extraembryonic ectoderm and To determine whether the placental HSC activity lies translation). Not surprisingly, the placenta is 36% erythroid, as determined by Ter119 staining (Figure 2H ), within the GFP + fraction of cells, we sorted GFP + and GFP − cells from E12 transgenic placentas. One and and appears to have a high endothelial cell content, as judged by the fact that 40% of placental cells are 0.25 placenta equivalents of cells were injected into irradiated, adult recipients and were analyzed 1 and/or 4 CD31 + ( Figure 2D ). However, CD31 also marks cells of the trophoblast lineage (Cross et al., 2003a). Nonery-months later for donor cell engraftment. As shown in Table 1 , all HSC activity was found in the GFP + fraction. throid hematopoietic cells make up 5.7%-7.
6% of the placenta (CD41-and CD45-positive cells; Figures 2I
These cells yielded high-level, long-term repopulation and contributed to all hematopoietic lineages (not and 2E, respectively). There is almost no overlap in Ter119 and Ly-6A GFP expression. However, 7%, 13%, shown). In addition, secondary transplantations of bone marrow showed that GFP + placental HSCs are selfre-15%, and 78% of the respective CD31 + , c-kit + , CD45 + , and CD34 + populations are Ly-6A GFP + . Most interest-newing (four positive/six injected, 1 month posttransplantation). Thus, all placental HSCs are Ly-6A GFP ingly, 75%, 66%, and 56% of GFP + cells express CD31, c-kit ( Figure 2F ), and CD34 ( Figure 2G ), respectively. expressing. However, since frequency analysis demonstrates that there are only approximately 12 HSCs per Since AGM HSCs coexpress c-kit and CD34, we 
3O) and transverse sections (Figures 3A-3C, 3E-3G, and 3I-3K). CD31 is expressed in many cells of the outer placenta spongiotrophoblast layer (Figures 3A-E12 placenta, not all GFP + cells are HSCs. These re-3C and 3M). It is highly expressed on the cells of the sults are consistent with previous findings in the AGM dilated maternal blood vessels and at a lower level on region for GFP + cells. endothelial cells in the labyrinth. It is also expressed by a few endothelial cells lining the vessels in the chorionic plate (Figure 3D). Expression begins in the outer GFP + Cells Localize to Vascular Labyrinth
Since flow cytometric analysis demonstrated that GFP + layer at E9 and by E12 is found also in the inner placenta, although at lower levels. CD34 is expressed cells were distributed between the cell fractions characterized by both endothelial and hematopoietic stem/ exclusively in the cells of the inner placenta ( Figures  3E-3G, 3N) , where it seems to outline the embryonic progenitor markers, we took a temporal and spatial immunostaining approach to examine the specific lo-vessels ( Figure 3H ). Expression is low at E9 and E10 and increases thereafter. In complete contrast to CD31 calization of these cells. We stained Ly-6A GFP transgenic placentas from E9 (not shown) and E10-E12 em-and CD34, CD41 shows a punctate expression pattern Figures 3I-3K, 3O) , where (not shown). The expression of c-kit was highest on the embryonic face of the placenta. it predominantly marks cells within the blood vessels ( Figure 3L) .
The general expression pattern of Ly-6A GFP is very similar to that of CD34, as expected from the results of In situ hybridization was performed to localize c-kitexpressing cells in the placenta, since high background the flow cytometric analysis (78% of CD34 + cells are GFP + ). Expression begins at E9 in some of the cells of staining was observed with c-kit-specific antibodies. As shown in Figure 4A , c-kit expression is found in the labyrinth and increases thereafter. GFP + cells are also found lining the fetal blood vessels in the chorionic mesenchymal cells of the chorionic plate (black arrow) and in islands of mesenchymal cells in the labyrinth plate and in the umbilical vessel (arrowheads in Figures  3A and 3E) . Most of the overlap in the expression of (white arrows). Many of the vessels also contained c-kit-expressing endothelial cells (arrowheads). We also GFP with CD34 is in the labyrinth region ( Figure 3F) in the endothelial cells lining the fetal vessels that form a detected expression in some trophoblast giant cells network through this region. There appears to be only a in the midgestation aorta (Minegishi et al., 1999; Zhou et al., 1998) . small amount of overlap of CD31 with GFP-expressing cells, confirming flow cytometric data (only 7% of Runx1 expression appears to localize to cells within the blood vessels of the labyrinth (in the circulation, as CD31 + cells are GFP + ). These cells are found in the large embryonic vessels within the chorionic plate and well as cells attached to the lumenal side of the endothelium), to endothelial cells (Figures 4H-4J ), and to also in the umbilical artery ( Figures 3A and 3D and Figure 1E) . We observed no overlap in the expression of cells located just underneath the endothelium (arrows in Figure 4I ). Occasionally, we see clusters of β-galacto-CD41 and GFP (Figures 3J and 3L) . Thus, these immunostaining and in situ transcription results taken to-sidase-positive cells within the circulation or attached to the endothelium. There also seems to be an accumu-gether with the multicolor flow cytometric analysis and the finding that all HSCs are GFP + strongly suggest that lation of positive cells in the chorionic plate ( Figure 4G) . These Runx1-expressing cells are located both within placental HSCs are localized within the endothelium of the embryonic vessels in the chorionic and labyrinth re-the walls of the vessels and surrounding the major blood vessels at their junction with the umbilical ves-gions. sels ( Figure 4G) . Thus, the distribution of Runx1expressing cells amongst hematopoietic, endothelial, Placental Embryonic Vessel Endothelium Expresses and mesenchymal cells is similar to what has been re-Hematopoietic Transcription Factors ported for Runx1-expressing cells in the AGM and sug-To further explore whether HSCs in the placenta may gests that Runx1 may also be involved in the generabe generated in situ, we examined the expression tion of HSCs in the placenta ( The expression pattern of all three transcription Our transplantation data show that prior to E11, placental HSC activity appears to be limiting. We found no factors differed. In GATA2 lacZ transgenic placental sections, we found some expression in trophoblast gi-HSCs in the placenta at E9 or E10. At E11, only one out of five transplanted recipients receiving two tissue ant cells, as reported previously (arrowhead in Figure  4B ). However, higher levels of β-galactosidase staining equivalents of placental cells is HSC engrafted. At E12, we found 12 HSCs per placenta. In more recent experi-were found in the labyrinth (Figures 4B and 4C ). An increasing intensity of staining was observed toward ments (not shown), we found that HSC numbers in the placenta begin to decrease at E13 and disappear there-the fetal side of the placenta, especially on the borders of the labyrinth region with the chorionic plate. GATA2 after. Thus, the numbers of HSCs in the placenta increase rapidly with developmental time and peak at is expressed in some endothelial cells and in the underlying cells that surround the fetal blood vessels (Fig-E12-E13 . Indeed, large numbers of immature progenitors have been found previously in the placenta and ure 4D). Like GATA2, GATA3 is expressed in the trophoblast giant cells, although to higher levels (Figures 4E  greatly exceed the numbers found in the fetal liver (Alvarez-Silva et al., 2003) . Others have shown that the and 4F, arrowheads). In contrast to GATA2, GATA3 expression is restricted to only these few cells at the fetal-human placenta secretes hematopoietic growth factors that stimulate hematopoietic colony formation (Bur-maternal interface. This pattern of expression confirms the previous pattern seen by others using in situ tran- gess et al., 1977) . More recent work demonstrates that mesenchymal progenitor cells isolated from the human scription analysis (Ng et al., 1994) . The endothelial expression of GATA2 (but not GATA3) is reminiscent of the placenta can expand long-term, culture-initiating cells from cord blood (Zhang et al., 2004) . Hence, the he-expression of GATA2 at the onset of HSC emergence mouse embryo, including HSCs, prompted our studies on the placenta. The Ly-6A GFP transgenic marker was found to be expressed in the endothelial cells lining the major vessels of the placenta. Moreover, all HSC activity was attributed to the GFP + fraction of the placenta. Thus, consistent with previous data, the Ly-6A GFP expression again marks all HSCs. While the number of GFP + cells in the placenta far exceeds the number of HSCs, other markers (such as CD34, CD31, c-kit, etc. ) were used to further localize placental HSCs. Previous studies on the AGM have shown that all AGM HSCs are c-kit + CD34 + (Sanchez et al., 1996) and CD31 + (North et al., 2002) . Our multicolor flow cytometric analysis strongly suggests that placental HSCs are GFP + c-kit + CD34 + . 
thelial cells lining the vessels of the labyrinth. Moreover, c-kit expression was found in a few cells in this region by in situ transcription analysis. In no sections did we matopoietic growth capacity of the placenta is enor-
find prominent hematopoietic clusters with these phemous, and it is not surprising that it is a potent hematonotypic characteristics. However, we did observe rare poietic microenvironment for HSCs. Kumaravelu et al. (2002) found that at E12 there are 3.2 the associated hematopoietic clusters, these markers HSCs in circulation. Correcting for numbers of HSCs in may also indicate associations of these two lineages in tissues due to circulation, the AGM was found to conputative hemogenic endothelium of the placenta. tain 2.7 HSCs, the YS 1.8, the liver 53, and the umbilical cord 0.8. Given that the E12 placenta contains 12 HSCs (four times more HSCs than in the whole of the embry-A Role for Transcription Factors GATA2 and Runx1 in Placental Hematopoiesis? onic blood), and considering that the fetal liver contains 53 HSCs at E12, it is highly likely that the placenta is a Previously, it was reported that GATA2 and GATA3 are highly expressed in the placenta in the trophoblast gi-potent HSC contributor to the colonization of the fetal liver, along with the AGM and YS.
single GFP + cells adhering closely to the lumenal sur-Recently, quantitative data on the numbers of HSCs face of the larger vessels. Thus, in analogy to the AGM present in the various hematopoietic tissues and circuregion in which GFP and CD34/CD31 are coexpressed lation in the midgestation mouse have been presented. in the ventral aortic endothelial cells and some cells of
ant cells positioned at the embryonic-maternal interface during midgestation (Ng et al., 1994) . The GATA It is as yet uncertain whether the HSCs in the placenta are intrinsically or extrinsically generated. If the transcription factors regulate the expression of a number of trophoblast-specific genes, such as the prolactin placenta was found to contain HSCs at E10 or earlier, it would implicate the placenta as the first site of emer-hormone placenta lactogen I and the angiogenic factor proliferin (Ma et al., 1997; Ng et al., 1994) . These mole-gence of HSCs in the mouse embryo. Previously, to detect the onset of HSC activity in the E10 AGM region, it cules appear to play an important role in the neovascularization of the placenta in the interface region (Ma et was necessary to transplant 96 adult recipients with a total of 112 AGM tissue equivalents of cells to observe al., 1997). We also found expression of these transcription factors in trophoblast giant cells. The lower fre-the long-term, high-level, multilineage repopulation of 3 recipients (Muller et al., 1994) . Given the limited quency of GATA3-expressing trophoblast cells that we found most likely was a reflection of a haploinsuffi-number of mice transplanted with E10 placental cells in this study, it remains a possibility that the placenta ciency of GATA3 due to a defective targeted allele. Nonetheless, GATA3 was restricted in its expression to contains HSCs at this earlier time point. To address the issue of autonomous generation, we performed explant these cells and is known to rapidly decline in its expression after E10 (Ng et al., 1994) . cultures with whole placentas. While we could maintain HSCs in AGM explants, no HSCs could be maintained GATA2 had a much more widespread expression pattern than previously described. GATA2 was ex-in placentas. Thus, the origins of the HSCs in the placenta are unclear and await the results of lineage-mark-pressed in some endothelial cells lining the vessels of the labyrinth, as well as in many cells surrounding the ing approaches.
vessels -2 YAC d16Z mice (Zhou et al., 1998) and wild-type C57BL/6 females; and between male knockin Cbfa2 lz/+ frozen on dry ice, and 10 m cryosections were prepared. Immunohistochemical stainings were carried out as previously described (North et al., 1999) 
